Molecular changes in primary breast tumors and the nottingham histologic score

Pathology and Oncology Research

Volumn 15, Issue 4, 2009, Pages 541-547

  Ellsworth, Rachel E ^a   Hooke, Jeffrey A ^b   Love, Brad ^c   Ellsworth, Darrell L ^d   Shriver, Craig D ^b  

^a Henry M Jackson Foundation for the Advancement of Military Medicine   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c INVITROGEN CORPORATION   (United States)

^d WINDBER RESEARCH INSTITUTE   (United States)

Author keywords

Allelic imbalance; Grade; Mitosis; Nuclear atypia; Tubule formation

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CELL ULTRASTRUCTURE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 9P; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS INDEX; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ALLELIC IMBALANCE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; FEMALE; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; MITOSIS; PROGNOSIS;

EID: 75049085187     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9151-3     Document Type: Article

References (39)

1. HJ Bloom WW Richardson 1957 Histological grading and prognosis in breast cancer Br J Cancer 11 359 377 1:STN:280:DyaG1c%2Fkt1Gmtg%3D%3D 13499785
2. CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology 19 403 410 1:STN:280: DyaK38%2FpvVSltw%3D%3D
3. DE Henson L Ries LS Freedman M Carriaga 1991 Relationship among outcome, stage of disease, and histologic grade for 22, 616 cases of breast cancer Cancer 68 2142 2149 10.1002/1097-0142(19911115)68:10<2142::AID-CNCR2820681010>3. 0.CO;2-D 1:STN:280:DyaK38%2FgsFWltw%3D%3D 1913453
4. P Robbins S Pinder N de Klerk, et al. 1995 Histological grading of breast carcinomas: a study of interobserver agreement Hum Pathol 26 873 879 10.1016/0046-8177(95)90010-1 1:STN:280:DyaK2Mzmt1ahtA%3D%3D 7635449
5. T Sorlie CM Perou R Tibshirania, et al. 2001 Gene Expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874 10.1073/pnas.191367098 1:CAS:528: DC%2BD3MXntVGmsbo%3D 11553815 (Pubitemid 32878711)
6. T Sorlie R Tibshirania J Parker, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 10.1073/pnas.0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D 12829800 (Pubitemid 36842560)
7. S Paik S Shak G Tang, et al. 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817 2826 10.1056/NEJMoa041588 1:CAS:528:DC%2BD2MXhslymsw%3D%3D 15591335 (Pubitemid 40051905)
8. S Ramaswamy KN Ross ES Lander TR Golub 2003 A molecular signature of metastasis in primary solid tumors Nat Genet 33 49 54 10.1038/ng1060 1:CAS:528:DC%2BD38XpvVeqs7w%3D 12469122 (Pubitemid 36068681)
9. LJ van't Veer H Dai MJ vande Vijver, et al. 2002 Gene expression profiling predicts clincial outcome of breast cancer Nature 415 530 536 10.1038/415530a (Pubitemid 34130608)
10. C Sotiriou P Wirapati S Loi, et al. 2006 Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 98 262 272 1:CAS:528:DC%2BD28Xhs1Skt74%3D 16478745
11. RE Ellsworth JA Hooke B Love, et al. 2008 Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors Breast Cancer Res Treat 107 259 265 10.1007/s10549-007-9547-2 17351743 (Pubitemid 350265696)
12. R Roylance P Gorman W Harris, et al. 1999 Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer Cancer Res 59 1433 1436 1:CAS:528:DyaK1MXisVWktLo%3D 10197608
13. R Roylance P Gorman A Hanby I Tomlinson 2002 Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways J Pathol 196 32 36 10.1002/path.1006 1:CAS:528:DC%2BD38XhtFOhs7c%3D 11748639 (Pubitemid 34071576)
14. DL Ellsworth CD Shriver RE Ellsworth B Deyarmin RI Somiari 2003 Laser capture microdissection of paraffin-embedded tissues Biotechniques 34 42 46 1:CAS:528:DC%2BD3sXktlyjsg%3D%3D 12545536
15. RE Ellsworth DL Ellsworth SM Lubert, et al. 2003 High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer Cancer Epidemiol Biomarkers Prev 12 915 919 1:CAS:528:DC%2BD3sXnsValt7g%3D 14504204
16. IL Medintz C-CR Lee WW Wong, et al. 2000 Loss of heterozygosity assay for molecular detection of cancer using energy-transfer primers and capillary array electrophoresis Genome Res 10 1211 1218 10.1101/gr.10.8.1211 1:CAS:528:DC%2BD3cXmtFels70%3D 10958639 (Pubitemid 30702298)
17. RE Ellsworth DL Ellsworth DM Neatrour, et al. 2005 Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes Mol Cancer Res 3 71 77 10.1158/1541-7786.MCR-04-0180 1:CAS:528:DC%2BD2MXitVKku7o%3D 15755873 (Pubitemid 40271137)
18. PL Fitzgibbons DL Page D Weaver, et al. 2000 Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 966 978 1:STN:280:DC%2BD3czptVKrtQ%3D%3D 10888772
19. A Fechter I Buettel E Kuehnel L Savelyeva M Schwab 2007 Common fragile site RFA11G and rare fragile site FRA11B at 11q23.3 encompass distinct genomic regions Genes Chromosomes Cancer 46 98 106 10.1002/gcc.20389 1:CAS:528:DC%2BD28Xht1GntrnL 17063465 (Pubitemid 44772876)
20. N Srivastava S Gochhait P Gupta RNK Bamezai 2008 Copy number alterations of the H2AFX gene in sporadic breast cancer patients Genes Chromosomes Cancer 180 121 128 1:CAS:528:DC%2BD1cXovFahug%3D%3D
21. A Bagchi C Papazoglu Y Wu, et al. 2007 CHD5 is a tumor suppressor at human 1p36 Cell 128 459 475 10.1016/j.cell.2006.11.052 1:CAS:528: DC%2BD2sXit1Wlt7k%3D 17289567 (Pubitemid 46198889)
22. RE Ellsworth DL Ellsworth B Love, et al. 2007 Correlation of levels and patterns of genomic instability with histological grading of DCIS Ann Surg Onc 14 3070 3077 10.1245/s10434-007-9459-8 (Pubitemid 47594271)
23. I Bieche R Lidreau 2000 Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer Mol Carcinog 29 151 158 10.1002/1098-2744(200011)29:3<151::AID-MC4>3.0.CO;2-6 1:CAS:528: DC%2BD3cXoslWru74%3D 11108660
24. H Buerger EC Mommers R Littmann, et al. 2001 Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution J Pathol 194 165 170 10.1002/path.875 1:CAS:528: DC%2BD3MXks1Klsrw%3D 11400144 (Pubitemid 32519965)
25. AM Cleton-Jansen H Buerger NT ter Haar, et al. 2004 Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer Genes Chromosomes Cancer 41 109 116 10.1002/gcc.20070 1:CAS:528:DC%2BD2cXnslWlurc%3D 15287023 (Pubitemid 39096736)
26. T van Wezel M Lombaerts EH van Roon, et al. 2005 Expression analysis of candidate breast tumor suppressor genes on chromosome 16q Breast Cancer Res 7 R998 R1004 10.1186/bcr1337 16280054
27. H Blegen JS Will BM Ghadimi, et al. 2003 DNA amplifications and aneuploidy, high proliferative activity and impaired cell cycle control characterize breast carcinomas with poor prognosis Anal Cell Pathol 25 103 114 1:CAS:528:DC%2BD3sXjvF2ksL0%3D 12775914
28. S Seitz K Poppe J Fischer, et al. 2001 Detailed deletion mapping in sporadic breast cancer at chromosomal region17p13 distal to the TP53 gene: association with clinicopathological parameters J Pathol 194 318 326 10.1002/1096-9896(200107)194:3<318::AID-PATH881>3.0.CO;2-4 1:CAS:528:DC%2BD3MXlsFSqsLk%3D 11439364 (Pubitemid 32624558)
29. R Winqvist GM Hampton A Mannermaa, et al. 1995 Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis Cancer Res 55 2660 2664 1:CAS:528:DyaK2MXmtlWrt7o%3D 7780982
30. H Tsuda S Hirohashi 1994 Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer Int J Cancer 57 498 503 10.1002/ijc.2910570410 1:CAS:528:DyaK2MXivVWjsg%3D%3D 7910151 (Pubitemid 24173093)
31. Q Yang I Mori T Sakurai, et al. 2001 Correlation between nuclear grade and biological prognostic variables in invasive breast cancer Breast Cancer 8 105 110 10.1007/BF02967488 1:CAS:528:DC%2BD3MXlt1SktrY%3D 11342982
32. AM Hanby DP Kelsell HW Potts, et al. 2007 Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer Int J Cancer 88 204 208 10.1002/1097-0215(20001015)88:2<204:: AID-IJC9>3.0.CO;2-1
33. KJ Patel VP Yu H Lee, et al. 1998 Involvement of Brca2 in DNA repair Mol Cell 1 347 357 10.1016/S1097-2765(00)80035-0 1:CAS:528:DyaK1cXhtlyhtbs%3D 9660919
34. X Han H Saito Y Miki A Nakanishi 2008 A CRM1-mediated nuclear export signal governs cytoplasmic localization of BRCA2 and is essential for centrosomal localization of BRCA2 Oncogene 27 2969 2977 10.1038/sj.onc.1210968 1:CAS:528:DC%2BD1cXlsFClt7o%3D 18059333 (Pubitemid 351668015)
35. F Rank P Dombernowsky NC Jespersen BV Pedersen N Keiding 1987 Histologic malignancy grading of invasive ductal breast carcinoma A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial. Cancer 60 1299 1305 1:STN:280:DyaL2szgtFantw%3D%3D
36. H Tsuda F Akiyama M Kurosumi G Sakamoto T Watanabe 1998 Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section Jpn J Clin Oncol 28 486 491 10.1093/jjco/28.8.486 1:STN:280:DyaK1cvktF2iug%3D%3D 9769782
37. K Komaki N Sano A Tangoku 2006 Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer Breast Cancer 13 249 253 10.2325/jbcs.13.249 16929117
38. G Berx AM Cleton-Jansen F Nollet, et al. 1995 E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers EMBO 14 6107 6115 1:CAS:528:DyaK28XjtVKjtQ%3D%3D
39. PT Simpson JS Reis-Filho MB Lambros, et al. 2008 Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas J Pathol 215 231 244 10.1002/path.2358 1:STN:280:DC%2BD1cvntVOnsA%3D%3D 18473330 (Pubitemid 351956704)